Discussant presentation : serotonin partial agonists in the treatment of depressionDIMITRIOU, E.The Journal of clinical psychiatry. 1990, Vol 51, Num SEP, pp 65-66, issn 0160-6689, 2 p., SupplConference Paper

Effect of m-chlorophenylpiperazine on plasma homovanillic acid concentrations in healthy subjectsKAHN, R. S; KNOTT, P; GABRIEL, S et al.Biological psychiatry (1969). 1992, Vol 32, Num 11, pp 1055-1061, issn 0006-3223Article

Molecular biology of the 5-HT₁ receptor subfamilyHARTIG, P. R; ADHAM, N; ZGOMBICK, J et al.Drug development research. 1992, Vol 26, Num 3, pp 215-224, issn 0272-4391Article

Alpha-methyltryptophan as a therapeutic agentSOURKES, T. L.Progress in neuro-psychopharmacology & biological psychiatry. 1991, Vol 15, Num 6, pp 935-938, issn 0278-5846Article

Serotonin, serotonin receptors, serotonin receptor subtype agonists and painPASCUAL, J.Pain (Amsterdam). 1990, Vol 40, Num 1, pp 115-116, issn 0304-3959Article

Behavioral indications for serotonin receptor hypersensitivity in panic disorderKAHN, R. S; WETZLER, S; VAN PRAAG, H. M et al.Psychiatry research. 1988, Vol 25, Num 1, pp 101-104, issn 0165-1781Article

Drug reactions : sumatriptan and chest painHILLIS, W. S; MACINTYRE, P. D.Lancet (British edition). 1993, Vol 341, Num 8860, pp 1564-1565, issn 0140-6736Article

II sumatriptan nella terapia dell'emicrania = Sumatriptan and migraineAMETRANO, P; ABU HWEIJ, F.Archivio di medicina interna (Parma). 1993, Vol 45, Num 2, pp 73-77, issn 0004-010XArticle

Changes in attitude toward food by obese patients treated with placebo and serotoninergic agentsBAGIELLA, E; CAIRELLA, M; DEL BEN, M et al.Current therapeutic research. 1991, Vol 50, Num 2, pp 205-210, issn 0011-393XArticle

Theoretical determination of the putative receptor-bound conformations of 5-HT₂ receptor agonistsHÖLTJE, H.-D; BRIEM, H.Quantitative structure-activity relationships. 1991, Vol 10, Num 3, pp 193-197, issn 0931-8771Article

Neurochemistry and neurophysiology of buspirone and gepirone : interactions at presynaptic and postsynaptic 5-HT_1A receptorsYOCCA, F. D.Journal of clinical psychopharmacology. 1990, Vol 10, Num 3, pp 6S-12S, issn 0271-0749, supplConference Paper

The Counteraction of Opioid-lnduced Ventilatory Depression by the Serotonin lA-Agonist 8-OH-DPAT Does Not Antagonize Antinociception in Rats In Situ and In VivoGUENTHER, Ulf; MANZKE, Till; WRIGGE, Hermann et al.Anesthesia and analgesia. 2009, Vol 108, Num 4, pp 1169-1176, issn 0003-2999, 8 p.Article

The longitudinal effects of fenfluramine-phentermine useFLEMING, Richard M; BOYD, Larry B.Angiology. 2007, Vol 58, Num 3, pp 353-359, issn 0003-3197, 7 p.Article

A validated chiral CE method for Frovatriptan, using cyclodextrin as chiral selectorKHAN, Muzaffar; VISWANATHAN, Balaji; SREENIVAS RAO, D et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 4, pp 1447-1452, issn 0731-7085, 6 p.Article

Sumatriptan does not affect vasopressin secretion in humansBARRECA, T; FRANCESCHINI, R; CATALDI, A et al.Clinical neuropharmacology. 1993, Vol 16, Num 6, pp 555-558, issn 0362-5664Article

Studies on the enhancement of 5-hydroxytryptamine-mediated behaviour by chlormethiazole and phenytoinGREEN, A. R; DE SOUZA, R. J; CROSS, A. J et al.Journal of psychopharmacology (Oxford). 1992, Vol 6, Num 3, pp 370-375, issn 0269-8811Article

A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteersLAWLOR, B. A; NEWHOUSE, P. A; BALKIN, T. J et al.Biological psychiatry (1969). 1991, Vol 29, Num 3, pp 281-286, issn 0006-3223, 6 p.Article

Novel enteric 5-HT₄ receptors and gastrointestinal prokinetic actionTONINI, M; RIZZI, C. A; MANZO, L et al.Pharmacological research. 1991, Vol 24, Num 1, pp 5-14, issn 1043-6618Article

Stereospecific inhibition of non-opioid defeat analgesia in male mice by MDL 72832, a selective 5-HT_1A receptor agonistRODGERS, R. J; SHEPHERD, J. K.European journal of pharmacology. 1990, Vol 182, Num 3, pp 581-585, issn 0014-2999, 5 p.Article

Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazineBREWERTON, T. D; MURPHY, D. L; MUELLER, E. A et al.Clinical pharmacology and therapeutics. 1988, Vol 43, Num 6, pp 605-609, issn 0009-9236Article

Serotonin₂ agonist administration down-regulates rat brain serotonin₂ receptorsBUCKHOLTZ, N. S; ZHOU, D; FREEDMAN, D. X et al.Life sciences (1973). 1988, Vol 42, Num 24, pp 2439-2445, issn 0024-3205Article

Clinical efficacy of the 5-HT₃ antagonist ondansetron in alcohol abuse and dependenceSELLERS, E. M; TONEATTO, T; ROMACH, M. K et al.Alcoholism, clinical and experimental research. 1994, Vol 18, Num 4, pp 879-885, issn 0145-6008Article

Effect of the serotonin agonist, MD-212, on body temperature in schizophreniaHONG SHICK LEE; BASTANI, B; FRIEDMAN, L et al.Biological psychiatry (1969). 1992, Vol 31, Num 5, pp 460-470, issn 0006-3223Article

Tianeptine, a specific serotonin uptake enhancer, decreases ethanol intake in ratsDAOUST, M; COMPAGNON, P; LEGRAND, E et al.Alcohol and alcoholism (Oxford). 1992, Vol 27, Num 1, pp 15-17, issn 0735-0414Article

Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjectsKAHN, R. S; KALUS, O; WETZLER, S et al.Psychiatry research. 1990, Vol 33, Num 2, pp 189-198, issn 0165-1781, 10 p.Article